Gordon C. Ibeanu

A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin

Ronald J. Ferguson, Sonia M. F. de Morais, Simone Benhamou et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 199 citations

Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase

Debabrata Chakravarti, Gordon C. Ibeanu, Keizo Tano et al. · Journal of Biological Chemistry · 1991 · 144 citations · Full text

Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin

Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 127 citations

A Novel Transversion in the Intron 5 Donor Splice Junction of CYP2C19 and a Sequence Polymorphism in Exon 3 Contribute to the Poor Metabolizer Phenotype for the Anticonvulsant Drug S-Mephenytoin

Gordon C. Ibeanu, Joyce Blaisdell, Ronald J. Ferguson et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 108 citations

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians

Gordon C. Ibeanu, Joyce Blaisdell, Burhan I. Ghanayem et al. · Pharmacogenetics · 1998 · 98 citations

Molecular Pharmacology, Allelic Variant, Trp Substitution +12